NCT00255333View on ClinicalTrials.gov

INNO-105 in Patients With Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

March 31, 2007

Conditions
Tumors
Interventions
DRUG

INNO-105

Trial Locations (2)

21201

University of Maryland Greenebaum Cancer Center, Baltimore

75201

Mary Crowley Medical Research Center, Dallas

Sponsors
All Listed Sponsors
lead

Innovive Pharmaceuticals

INDUSTRY